Company Filing History:
Years Active: 2002-2003
Title: The Innovations of Andreas Kollmeyer-Seeger
Introduction
Andreas Kollmeyer-Seeger is a notable inventor based in Langenfeld, Germany. He has made significant contributions to the field of transdermal therapeutic systems, holding a total of 2 patents. His work focuses on innovative methods for drug delivery that enhance patient care and treatment efficacy.
Latest Patents
Kollmeyer-Seeger’s latest patents include a transdermal therapeutic system (TTS) containing oxybutynin. This system allows for the transcutaneous administration of oxybutynin over several days, utilizing a method for production that does not require solvents. The TTS features a matrix mass with oxybutynin in a self-adhesive layer, incorporating ammonium-group-containing (meth)acrylic polymers, at least one citric acid ester, and 5-25 wt. % oxybutynin. Another significant patent involves a transdermal therapeutic system containing pergolide. This invention also facilitates the transcutaneous administration of pergolide over several days, employing a solvent-free manufacturing method. The TTS consists of a matrix mass that includes pergolide and is structured as a layer, utilizing a (meth)acrylate copolymer with ammonio groups or a mixture of copolymers, along with 10-50% by weight propylene glycol and up to 5% by weight pergolide.
Career Highlights
Andreas Kollmeyer-Seeger is associated with Schwarz Pharma AG, where he has been instrumental in developing innovative therapeutic systems. His expertise in transdermal drug delivery systems has positioned him as a key figure in pharmaceutical advancements.
Collaborations
He has collaborated with notable colleagues such as Christoph Arth and Stephan Rimpler, contributing to the success of various projects within the company.
Conclusion
Andreas Kollmeyer-Seeger’s contributions to transdermal therapeutic systems exemplify his commitment to innovation in the pharmaceutical industry. His patents reflect a dedication to improving drug delivery methods, ultimately benefiting patient care.